These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 2242759)
1. Age-related decrement in cytotoxic T lymphocyte (CTL) activity is associated with decreased levels of mRNA encoded by two CTL-associated serine esterase genes and the perforin gene in mice. Bloom ET; Umehara H; Bleackley RC; Okumura K; Mostowski H; Babbitt JT Eur J Immunol; 1990 Oct; 20(10):2309-16. PubMed ID: 2242759 [TBL] [Abstract][Full Text] [Related]
2. Functional importance of CD4+ and CD8+ cells in cytotoxic lymphocytes activity and associated gene expression. Impact on the age-related decline in lytic activity. Bloom ET Eur J Immunol; 1991 Apr; 21(4):1013-7. PubMed ID: 1673431 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. Lancki DW; Hsieh CS; Fitch FW J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149 [TBL] [Abstract][Full Text] [Related]
4. Pore-forming protein in individual cytotoxic T lymphocytes: the effect of senescence provides a probe for understanding the lytic mechanism. Horvath JA; Mostowski HS; Okumura K; Bloom ET Eur J Immunol; 1992 Oct; 22(10):2649-54. PubMed ID: 1396969 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. Bloom ET; Horvath JA J Immunol; 1994 May; 152(9):4242-54. PubMed ID: 7908914 [TBL] [Abstract][Full Text] [Related]
6. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes. Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700 [TBL] [Abstract][Full Text] [Related]
7. Expression of mRNAs for pore-forming protein and two serine esterases in murine primary and cloned effector lymphocytes. Joag SV; Liu CC; Kwon BS; Clark WR; Young JD J Cell Biochem; 1990 May; 43(1):81-8. PubMed ID: 2347877 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes. Berke G; Rosen D; Ronen D Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395 [TBL] [Abstract][Full Text] [Related]
9. [Cytotoxic molecules, perforin and serine esterase in cytotoxic T lymphocyte]. Koizumi H Arerugi; 1989 Jan; 38(1):41-8. PubMed ID: 2787151 [TBL] [Abstract][Full Text] [Related]
10. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity. Kuwano K; Akashi A; Arai S Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689 [TBL] [Abstract][Full Text] [Related]
11. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies. Hommel-Berrey G; Bochan M; Brahmi Z Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201 [TBL] [Abstract][Full Text] [Related]
12. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. Berke G; Rosen D J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity. Makrigiannis AP; Hoskin DW J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393 [TBL] [Abstract][Full Text] [Related]
14. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902 [TBL] [Abstract][Full Text] [Related]
15. Expression of perforin in murine natural killer cells and cytotoxic T lymphocytes in vivo. Kawasaki A; Shinkai Y; Yagita H; Okumura K Eur J Immunol; 1992 May; 22(5):1215-9. PubMed ID: 1577064 [TBL] [Abstract][Full Text] [Related]
16. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets. Smyth MJ; Norihisa Y; Ortaldo JR J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790 [TBL] [Abstract][Full Text] [Related]
17. Serine esterase in cytolytic T lymphocytes. Pasternack MS; Verret CR; Liu MA; Eisen HN Nature; 1986 Aug 21-27; 322(6081):740-3. PubMed ID: 3489187 [TBL] [Abstract][Full Text] [Related]
18. Transgenic control of perforin gene expression. Functional evidence for two separate control regions. Lichtenheld MG; Podack ER; Levy RB J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890 [TBL] [Abstract][Full Text] [Related]
19. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Williams NS; Engelhard VH J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456 [TBL] [Abstract][Full Text] [Related]
20. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]